Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
BioPharma Dive2d
Drugmakers prep for bird flu outbreak, despite continued low risk
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
HealthDay on MSN6d
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
AOL6d
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about ...
Should we be worried about bird flu, the 'unpredictable shape-shifter?'
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...
Moderna: The Good News Isn't Enough
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Experts are anxious that bird flu could become airborne — and jump-start another pandemic
Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...
Bird flu isn't an immediate health threat in New York, but preparations have begun
As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...